Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 84,908
  • Shares Outstanding, K 20,760
  • Annual Sales, $ 67,190 K
  • Annual Income, $ -97,330 K
  • 36-Month Beta 0.03
  • Price/Sales 1.11
  • Price/Cash Flow 0.00
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.90
  • Most Recent Earnings -0.13 on 05/15/17
  • Next Earnings Date 08/03/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2860 Industrial Organic Chemicals

    Biofuels

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.67 +53.18%
on 06/22/17
4.32 -5.32%
on 07/20/17
+1.38 (+50.92%)
since 06/21/17
3-Month
2.63 +55.51%
on 06/21/17
9.30 -56.02%
on 05/01/17
-3.86 (-48.55%)
since 04/21/17
52-Week
2.63 +55.51%
on 06/21/17
18.15 -77.47%
on 10/19/16
-1.76 (-30.09%)
since 07/21/16

Most Recent Stories

More News
Amyris Enters Into First Product Development and Production Agreement With Royal DSM For Food and Nutrition Molecule

Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announces that it has entered into its first product development and production agreement with Koninklijke DSM N.V. (Royal DSM) (AEX:DSM.AS),...

AMRS : 4.09 (-0.97%)
Breakfast Technical Briefing on Specialty Chemicals Stocks -- Amyris, LyondellBasell Industries, Platform Specialty Products, and Axalta Coating Systems

If you want a Stock Review on AMRS, LYB, PAH or AXTA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com shifts focus on Amyris...

AMRS : 4.09 (-0.97%)
LYB : 86.87 (-0.17%)
PAH : 12.96 (+1.57%)
AXTA : 32.50 (-1.52%)
3-DAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 16, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) for possible violations...

AMRS : 4.09 (-0.97%)
MONDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (Nasdaq:AMRS) for possible violations of federal securities laws....

AMRS : 4.09 (-0.97%)
AMRS EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Amyris, Inc. and a Lead Plaintiff Deadline of June 19, 2017

NEW YORK, NY / ACCESSWIRE / June 15, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California...

AMRS : 4.09 (-0.97%)
4-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / June 15, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a securities class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS). Investors,...

AMRS : 4.09 (-0.97%)
AMRS DEADLINE NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important June 19 Deadline in First Filed Class Action - AMRS

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Amyris, Inc. securities (NASDAQ: AMRS) from March 2, 2017 through April 17, 2017, both dates inclusive (the "Class Period") of the...

AMRS : 4.09 (-0.97%)
Law Offices of Howard G. Smith Reminds Amyris, Inc. Investors of Pending Lawsuit and Upcoming Lead Plaintiff Deadline

Law Offices of Howard G. Smith reminds investors of the upcoming June 19, 2017 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of a class of investors...

AMRS : 4.09 (-0.97%)
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amyris, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2017 - AMRS

NEW YORK, NY / ACCESSWIRE / June 14, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

AMRS : 4.09 (-0.97%)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline - June 19, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ:AMRS) securities and certain...

AMRS : 4.09 (-0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Support & Resistance

2nd Resistance Point 4.34
1st Resistance Point 4.22
Last Price 4.09
1st Support Level 3.95
2nd Support Level 3.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.